ZBH - Company ID 0001136869
The table below shows ZIMMER BIOMET HOLDINGS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B |
| Cost of revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
ZIMMER BIOMET HOLDINGS, INC. reported annual revenue of $8.23B for fiscal year 2025. That is up 7.2% from $7.68B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $7.67B (FY 2016) to $8.23B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.26B |
| $2.93B |
| $2.84B |
| $2.76B |
| $2.84B |
| $2.71B |
| Operating income | $1.10B | $1.29B | $1.28B | $696.30M | $860.30M | $83.10M |
| Income tax | $125.70M | $131.40M | $42.20M | $112.30M | $53.50M | -$96.00M |
| Net income | $705.10M | $903.80M | $1.02B | $231.40M | $401.60M | -$138.90M |
| EPS (diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | -$0.67 |